Keymed Biosciences Inc. (HKG:2162)
Hong Kong
· Delayed Price · Currency is HKD 45.00
+1.05 (2.39%)
Apr 24, 2025, 4:08 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 12.40 billion as of April 24, 2025. Its market cap has increased by 37.28% in one year.
Market Cap
12.40B
Enterprise Value
10.91B
Revenue
455.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
45.00
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has decreased from 18.43B to 12.40B, a decrease of -32.70%. That is a compound annual growth rate of -9.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 12.11B | 42.23% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.77% |
| Dec 30, 2022 | 14.27B | 47.83% |
| Dec 31, 2021 | 9.65B | -47.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 191.64B |
| Hansoh Pharmaceutical Group Company | 131.15B |
| JD Health International | 113.19B |
| WuXi Biologics | 82.98B |
| Innovent Biologics | 77.88B |
| Akeso | 74.45B |
| Alibaba Health Information Technology | 73.50B |
| Sino Biopharmaceutical | 65.67B |